OTC Pricing Pressures Will Grow As Uninsured Self-Medicate – Consultant
This article was originally published in The Tan Sheet
Executive Summary
OTC drugs will play a larger role in the healthcare debate as prescription drug prices continue to rise, according to Kay Holcombe, VP for Washington, D.C.-based consulting firm Policy Directions
You may also be interested in...
“MedWise Prescription” Education Campaign Targets Rx-OTC Interactions
The latest "MedWise" consumer education campaign will focus on warning patients against the potential for overdosing when mixing OTC and prescription drugs with the same active ingredients
FDA Announces “Proactive” Approach To Rx-To-OTC Switches
FDA plans to take a more active role in initiating Rx-to OTC switches in coming years, Senior Associate Commissioner for Management & Systems Jeff Weber said Feb. 3
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC